Octaplas Available for Blood Clotting Disorders

Octapharma announced that Octaplas, a solvent detergent treated, pooled human plasma is now available.

Octaplas is indicated for:

  • Replacement of multiple coagulation factors in patients with acquired deficiences due to liver disease or undergoing cardiac surgery or liver transplant
  • Plasma exchange in patients with thrombotic thrombocytopenic purpura (TPP)

RELATED: Hematological Disorders Resource Center

Octaplas is a sterile, frozen solution of pooled human plasma from several donors that has been treated with a solvent detergent process. This process kills certain viruses and thereby minimizes the risk of serious virus transmission. 

The plasma used to manufacture Octaplas is collected from U.S. donors who have been screened and tested for diseases transmitted by blood, and determined to be suitable donors. 

Like Fresh Frozen Plasma, Octaplas should be matched to the recipient's blood group to help avoid transfusion reactions. Each lot is tested for composition of key clotting factors and is only released if the levels are within acceptable ranges.

Octaplas is available in polyvinyl chloride blood bags which contain 45–70mg/mL of human plasma proteins in a 200mL frozen solution.

For more information call (201) 604-1130 or visit Octaplasus.com.